Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Acinetobacter spp. isolates from Clinical samples 2018-2024

ABSTRACT: Acinetobacter spp. isolates from Clinical samples 2018-2024

PROVIDER: PRJEB89113 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Characterization functional of AcoN-like negative regulator protein from Acetoin cluster in Acinetobacter spp. Strains

Project description:Studies of expression of mechanims of defense of the Acinetobacter sp.5-2Ac.02 from airborne hospital environment under stress conditions, such as SOS response (ROS response, heavy metals resistant mechanisms, peptides), as well as Quorum network (acetoin cluster and aromatics biodegradation cluster). Characterization functional of AcoN-like as negative regulator protein from acetoin cluster in Acinetobacter spp. Strains

2019-07-16 | GSE120392 | GEO

Clinical Bifidobacterium spp. isolates

Project description:Clinical characterization and whole genome sequencing of 15 blood culture isolates of Bifidobacterium spp.

| PRJEB18553 | ENA

BAHA 2018 samples

Project description:BAHA 2018 samples Raw sequence reads

| PRJNA433072 | ENA

Acinetobacter sp. H1(2024)

Project description:Acinetobacter sp. H1(2024) Genome sequencing

| PRJNA1204183 | ENA

CPE/CPO isolates Ireland 2024

Project description:Isolates Received to the Irish National CPE Reference Laboratory in 2024

| PRJEB85326 | ENA

Antimicrobial resistance in clinical isolates of <i>Ureaplasma</i> spp. from samples in Germany.

Project description:Ureaplasma urealyticum and U parvum are mollicutes species that colonize the urogenital tract of many asymptomatic persons but are also thought to be associated with symptomatic infections. Using 170 strains isolated between 2016 and 2019 in a German university hospital, resistance was tested by a combination of commercial tests, molecular methods and determination of minimal inhibitory concentrations. Rates of resistance to macrolides, tetracyclines and fluoroquinolones were 0%, 4.1% and 7.1%, respectively.

| S-EPMC8092870 | biostudies-literature

Multiazole resistance in clinical and environmental fungal isolates

Project description:Whole genome sequencing of SYBARIS Aspergillus spp. known to be multi-drug resistant and difficult to treat. Aim of this experiment is to investigate the genetic basis of susceptibility to disease and elucidate molecular mechanisms of drug resistance in these strains.

2016-04-30 | E-SYBR-1 | biostudies-arrayexpress

Clinical S. Blockley isolates from Germany.

Project description:Clinical S. Blockley isolates from Germany from 2024.

| PRJEB88342 | ENA

Acinetobacter spp

Project description:Complete genome sequencing of carbapenem resistant Acinetobacter spp. clinical isolates

| PRJNA329669 | ENA

Streptococcus spp., Staphylococcus spp., Escherichia spp.

Project description:Streptococcus spp., Staphylococcus spp., Escherichia spp. Raw sequence reads

| PRJNA1081048 | ENA